AGP Executive Report
Last update: 10 hours agoVaccine Trial Dispute: Guinea-Bissau’s health minister says the country has not approved a controversial newborn hepatitis B study, contradicting claims that helped a Danish research ethics committee back the trial. The study would delay vaccination for some babies. Digital Kidney Care: A Danish trial found remote, patient-reported follow-up for chronic kidney disease patients was no worse clinically than routine care, but did not reduce costs or improve quality-adjusted survival over 18 months. Obesity Drug Research: Zealand Pharma’s new deal with Generate Biomedicines uses AI to develop protein treatments for obesity and other metabolic diseases, with payments potentially reaching nearly $1.2 billion, plus royalties. Diet and Dementia: A 27-year study by Danish researchers linked nitrate from leafy vegetables to lower dementia risk, while nitrate from drinking water and processed meat was associated with higher risk.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
